A CLYDEBANK-based company has been praised for its work in the coronavirus vaccine supply chain programme.

A recent report by the Scottish Government on life sciences and innovation in responding to Covid-19 has shown how businesses have helped make real progress in the fight against the virus.

And SGS UK Ltd, based in Clydebank Business Park, has been part of the process to develop a vaccine.

The town’s MSP, Gil Paterson, said: “SGS UK Ltd provides a comprehensive range of biopharmaceutical testing services, and has been deeply involved in the Covid-19 vaccine programmes, having joined the consortium with Oxford University to provide biosafety testing in April, and then partnering with European biotech company ReiThera to fast-track the development and production of a single-dose Covid-19 vaccine in June.

Read more: First tenants to move into homes on former St Andrew’s High site

“So confident was the Scottish Government that this company would succeed and make a significant contribution to the life science industry in Scotland they, through Scottish Enterprise, supported SGS UK Ltd.’s expansion project in 2017 worth £9.6 million, which created 19 new scientific jobs and safeguarded 50 existing ones.

“To further recognise SGS UK Ltd’s ambitions they have also received a research and development grant of £1.79million. Investment well-made I think.”